Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 371

Related Citations for PubMed (Select 23482775)

1.

Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y.

Anticancer Res. 2013 Mar;33(3):1013-21.

PMID:
23482775
2.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
3.

Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.

Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1417-24.

PMID:
19950803
5.
7.

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.

Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.

Am J Gastroenterol. 2006 Sep;101(9):2038-43. Epub 2006 Jul 18.

PMID:
16848811
8.

The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.

Soliman HH, Nagy H, Kotb N, Alm El-Din MA.

Int J Biol Markers. 2012 Jul 19;27(2):e125-31. doi: 10.5301/JBM.2012.9097.

PMID:
22388957
9.

Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.

Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.

Anticancer Res. 2003 Mar-Apr;23(2C):1747-53.

PMID:
12820452
11.

Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.

Morimoto M, Numata K, Nozaki A, Kondo M, Moriya S, Taguri M, Morita S, Konno M, Sugo A, Miyajima E, Maeda S, Tanaka K.

Int J Clin Oncol. 2012 Aug;17(4):373-9. doi: 10.1007/s10147-011-0306-3. Epub 2011 Aug 17.

PMID:
21847534
12.

Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.

Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.

World J Gastroenterol. 2013 Jan 21;19(3):339-46. doi: 10.3748/wjg.v19.i3.339.

13.

Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.

Hsieh MY, Lin ZY, Chuang WL.

Kaohsiung J Med Sci. 2011 Aug;27(8):314-22. doi: 10.1016/j.kjms.2011.03.008. Epub 2011 May 8.

PMID:
21802642
14.

[Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].

Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL.

Zhonghua Yi Xue Za Zhi. 2008 Jul 22;88(28):1986-8. Chinese.

PMID:
19062741
15.

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.

Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.

Am J Gastroenterol. 2000 Apr;95(4):1036-40.

PMID:
10763956
16.

Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.

Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H.

Oncol Rep. 2011 Nov;26(5):1227-33. doi: 10.3892/or.2011.1425. Epub 2011 Aug 19.

PMID:
21874252
17.

The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.

Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):394-402; quiz 267.

18.

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M.

Gastroenterology. 2009 Jul;137(1):110-8. doi: 10.1053/j.gastro.2009.04.005. Epub 2009 Apr 9.

19.

Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.

Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.

Chin Med J (Engl). 2002 Jan;115(1):42-5.

PMID:
11930656
20.

Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.

Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P.

J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.

PMID:
19793164
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk